tiprankstipranks
Pharmaxis Ltd (AU:SNT)
ASX:SNT
Holding AU:SNT?
Track your performance easily

Pharmaxis Ltd (SNT) Financial Statements

3 Followers

Pharmaxis Ltd Financial Overview

Pharmaxis Ltd's market cap is currently ―. The company's EPS TTM is AU$-0.021; its P/E ratio is -2.10; Pharmaxis Ltd is scheduled to report earnings on February 7, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19Jun 18
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 8.94MAU$ 18.71MAU$ 14.76MAU$ 31.12MAU$ 31.07M
Total AssetsAU$ 25.19MAU$ 33.59MAU$ 35.42MAU$ 52.67MAU$ 50.10M
Total DebtAU$ 4.29MAU$ 6.32MAU$ 8.15MAU$ 7.17MAU$ 8.27M
Net DebtAU$ -4.65MAU$ -12.39MAU$ -6.61MAU$ -23.95MAU$ -22.80M
Total LiabilitiesAU$ 14.38MAU$ 30.75MAU$ 33.98MAU$ 37.85MAU$ 38.98M
Stockholders EquityAU$ 10.80MAU$ 2.85MAU$ 1.43MAU$ 14.81MAU$ 11.12M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in AUD

Pharmaxis Ltd Earnings and Revenue History

Pharmaxis Ltd Debt to Assets

Pharmaxis Ltd Cash Flow

Pharmaxis Ltd Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis